Advisornet Financial’s ADMA Biologics ADMA Stock Holding History

Advisornet Financial’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500	Closed	-$9.99K	–	1969
2024 Q3	$9.99K	Hold	500	–	–	﹤0.01%	1420
2024 Q2	$5.59K	Hold	500	–	–	﹤0.01%	1444
2024 Q1	$3.3K	Hold	500	–	–	﹤0.01%	1515
2023 Q4	$2.26K	Hold	500	–	–	﹤0.01%	1682
2023 Q3	$1.79K	Hold	500	–	–	﹤0.01%	1665
2023 Q2	$1.84K	Hold	500	–	–	﹤0.01%	1740
2023 Q1	$1.66K	Hold	500	–	–	﹤0.01%	1758
2022 Q4	$1.94K	Hold	500	–	–	﹤0.01%	1676
2022 Q3	$1K	Hold	500	–	–	﹤0.01%	1730
2022 Q2	$1K	Hold	500	–	–	﹤0.01%	1758
2022 Q1	$1K	Hold	500	–	–	﹤0.01%	1839
2021 Q4	$1K	Buy	+500	New	+$657	﹤0.01%	1880

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Advisornet Financial's ADMA Position: Q4 2024 in Review

Advisornet Financial sold out of ADMA Biologics (ADMA) in Q4 2024, closing a stake of 500 shares — an estimated $9.99K sold.

Advisornet Financial first reported a position in ADMA in Q4 2021 and held it in 12 quarters. The position peaked at $9.99K in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q4 2024.

Advisornet Financial reported no remaining ADMA Biologics position as of Q4 2024 after selling out during the quarter.
Advisornet Financial sold 500 ADMA Biologics shares in Q4 2024, an estimated $9.99K.
Advisornet Financial first reported a position in ADMA Biologics in Q4 2021 and held it in 12 quarters.
Advisornet Financial's ADMA Biologics position peaked at $9.99K in Q3 2024.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2024.

Based on Advisornet Financial's 13F filing for Q4 2024, filed 13 Jan 2025.